Cargando…

Designing Studies to Inform Tobacco Harm Reduction: Learnings From an Oral Nicotine Pouch Actual Use Pilot Study

BACKGROUND: Introduction of new tobacco products in the United States, including those that may be lower on the risk continuum than traditional combustible cigarettes, requires premarket authorization by the US Food and Drug Administration and information on the potential impact of the products on c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campbell, Chris, Feehan, Michael, Kanitscheider, Claudia, Makena, Patrudu S, Cai, Jenny, Baxter, Sarah A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440415/ https://www.ncbi.nlm.nih.gov/pubmed/35984682 http://dx.doi.org/10.2196/37573

Ejemplares similares

The New Nicotine Pouch Category: A Tobacco Harm Reduction Tool?
por: Patwardhan, Sudhanshu, et al.
Publicado: (2021)

Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs)
por: Back, Susanne, et al.
Publicado: (2023)

Changes in Biomarkers of Exposure and Potential Harm in Smokers Switched to Vuse Vibe or Vuse Ciro Electronic Nicotine Delivery Systems
por: Kanobe, Milly N., et al.
Publicado: (2023)

Potential predictors of adoption of the Tobacco Heating System by U.S. adult smokers: An actual use study
por: Roulet, Steve, et al.
Publicado: (2021)

Global gene expression profiles from PBMCs treated with reference tobacco product preparations
por: Arimilli, Subhashini, et al.
Publicado: (2019)

Nicotine pharmacokinetics and subjective responses after using nicotine pouches with different nicotine levels compared to combustible cigarettes and moist smokeless tobacco in adult tobacco users
por: Liu, Jianmin, et al.
Publicado: (2022)

Differences in Young Adults’ Perceptions of and Willingness to Use Nicotine Pouches by Tobacco Use Status
por: Vogel, Erin A., et al.
Publicado: (2022)

Differential gene expression of 3D primary human airway cultures exposed to cigarette smoke and electronic nicotine delivery system (ENDS) preparations
por: Rayner, Rachael E., et al.
Publicado: (2022)

Oxidative Stress and Lung Fibrosis: Towards an Adverse Outcome Pathway
por: Makena, Patrudu, et al.
Publicado: (2023)

The effect of a non‐tobacco‐based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus)
por: Alizadehgharib, Sara, et al.
Publicado: (2022)

Perceptions of Oral Nicotine Pouches on Reddit: Observational Study
por: Shao, Yihan, et al.
Publicado: (2022)

Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV
por: Edwards, Stephanie, et al.
Publicado: (2022)

Biomarkers of Exposure and Potential Harm in Two Weeks of Smoking Abstinence: Changes in Biomarkers of Platelet Function, Oxidative Stress, and Inflammation
por: Makena, Patrudu, et al.
Publicado: (2023)

Heated Tobacco Products and Nicotine Pouches: A Survey of People with Experience of Smoking and/or Vaping in the UK
por: Brose, Leonie S., et al.
Publicado: (2021)

Tobacco-Derived Nicotine Pouch Brands and Marketing Messages on Internet and Traditional Media: Content Analysis
por: Ling, Pamela M, et al.
Publicado: (2023)

Perceptions of oral nicotine pouches & their marketing among Ohio Appalachia smokers and smokeless tobacco users
por: Long, Lauren, et al.
Publicado: (2023)

Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): The Study Protocol of an Uncontrolled Feasibility Study of Novel Nicotine Replacement Products among People Living with HIV Who Smoke
por: Bell, Stephanie, et al.
Publicado: (2017)

A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products
por: Azzopardi, David, et al.
Publicado: (2022)

Estimating the public health impact had tobacco-free nicotine pouches been introduced into the US in 2000
por: Lee, Peter N., et al.
Publicado: (2022)

The Correlation of Swedish Snus, Nicotine Pouches and Other Tobacco Products with Oral Mucosal Health and Salivary Biomarkers
por: Miluna, Sintija, et al.
Publicado: (2022)

Tobacco-free Nicotine Pouch Use in Great Britain: A Representative Population Survey 2020–2021
por: Tattan-Birch, Harry, et al.
Publicado: (2022)

The Effects of Oral Nicotine Pouch Packaging Features on Adult Tobacco Users’ and Non-Users’ Product Perceptions
por: Mays, Darren, et al.
Publicado: (2023)

Nicotine Pouch: Awareness, Beliefs, Use, and Susceptibility among Current Tobacco Users in the United States, 2021
por: Sparrock, Lindsey S., et al.
Publicado: (2023)

Tobacco Substitutes: Harm Reduction or Smokescreen?
Publicado: (2007)

Tobacco Substitutes: Snus and Harm Reduction
por: Szalavitz, Maia
Publicado: (2007)

A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette
por: McEwan, Michael, et al.
Publicado: (2021)

Nicotine pouches: a review for the dental team
por: M. Jackson, Joshua, et al.
Publicado: (2023)

Biomarkers of Exposure and Potential Harm in Exclusive Users of Nicotine Pouches and Current, Former, and Never Smokers: Protocol for a Cross-sectional Clinical Study
por: Azzopardi, David, et al.
Publicado: (2022)

Results from a 2018 cross-sectional survey in Tokyo, Osaka and Sendai to assess tobacco and nicotine product usage after the introduction of heated tobacco products (HTPs) in Japan
por: Adamson, Jason, et al.
Publicado: (2020)

Optimization of Normal Human Bronchial Epithelial (NHBE) Cell 3D Cultures for in vitro Lung Model Studies
por: Rayner, Rachael E., et al.
Publicado: (2019)

Introducing oral tobacco for tobacco harm reduction: what are the main obstacles?
por: Martinet, Yves, et al.
Publicado: (2007)

Tobacco Harm Reduction as a Path to Restore Trust in Tobacco Control
por: Antin, Tamar M. J., et al.
Publicado: (2021)

US Physicians’ Self-reported Discussions About Tobacco-Free Nicotine Pouches During Clinical Encounters With Patients in 2021
por: Hrywna, Mary, et al.
Publicado: (2023)

The scientific foundation for tobacco harm reduction, 2006-2011
por: Rodu, Brad
Publicado: (2011)

The Case in Favor of E-Cigarettes for Tobacco Harm Reduction
por: Nitzkin, Joel L.
Publicado: (2014)

Strategies for an effective tobacco harm reduction policy in Indonesia
por: Nurwidya, Fariz, et al.
Publicado: (2014)

Harmful effects of nicotine
por: Mishra, Aseem, et al.
Publicado: (2015)

Classification, Perception, and Toxicity of Emerging Flavored Oral Nicotine Pouches
por: Shaikh, Sadiya Bi, et al.
Publicado: (2023)

Awareness, susceptibility, and use of oral nicotine pouches and comparative risk perceptions with smokeless tobacco among young adults in the United States
por: Morean, Meghan E., et al.
Publicado: (2023)

Nicotine Pouch Sales Trends in the US by Volume and Nicotine Concentration Levels From 2019 to 2022
por: Majmundar, Anuja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_69fk2i5ne2ndgung6ok4pi1vv6